Skip to content
Study details
Enrolling now

Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge

Vanderbilt University Medical Center
NCT IDNCT06852950ClinicalTrials.gov data as of Apr 2026
Target enrollment

60

Study length

about 11 months

Ages

18+

Locations

1 site in TN

What this study is about

This trial is testing whether continuous glucose monitoring (CGM) helps people with diabetes manage their blood sugar levels better after they leave the hospital. The goal is to improve how well people understand and use CGM devices, as well as increase satisfaction with their overall diabetes care.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Use Dexcom G7 Continuous Glucose Monitor
  • 2.Use Libre 3 Plus Continuous Glucose Monitor

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
Randomized (Open Label)

You are randomly assigned, but you will know your treatment.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Secondary: Degree of Average Change in Hemoglobin A1C from Start to End of Study

Devices

monitoring

Body systems

Endocrinology